Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18737ApprovedWithdrawnSmall molecule
Procinonide: Overview.
- Formula / weight
- C27H34F2O7 · 508.559 g/mol (avg)
- First approval
- Canada, 1987
- Also known as
- 6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, 21-propionate · Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-21-(1-oxopropoxy)-, (6.alpha.,11.beta.,16.alpha)-
- Code names
- RS-2362
Resolves to
Structure
InChIKey
UBOIMZIXNXGQOH-RTWVSBIPSA-NSMILES[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12CWhat you can answer from here — as of March 06, 2025
Which companies are running trials of Procinonide, in which indications and phases, and which of those programs are still active?